Member Info for Trickymatters

Who were the other ecommerce names they're using as comparators? THG are growing faster than anyone in their industry sector. If it's Deliveroo or Ocado those are nonsense comparisons. If Boo or ASOS they've both issued profit warnings whilst THG issued an update featuring a blockbuster best ever £2.2 billion revenue, 22% growth and further expansion plans and investment in productivity that will blow BOO and ASOS out of the water.
Interesting that they value Ingenuity at 7x sales, noting the high value margins but if it was sold they are valuing it at 1x sales. LOL.
Very likely that the strategic plan will be exciting. Obviously I wish I had a crystal ball and then I might jump in and out on this volatility. But I am betting on the probability that they have a plan to sell Ingenuity. Sounds like Barclays are doing their analysis on the back of a fag packet to justify their opportunistic shorting between news flow. Disgrace. MM should sack them as brokers.

Your last post aged well Bluray. LOL. The CEO here suggested we will move into a news rich period once they've had the PFS. Should help the sp recover and flourish. Graphite is an essential component of lithium, for EV batteries. The headline targets are fantastic. Obviously a year away before any real production but I've seen industry targets for 27p and 33p in the next year, today, which I suppose is about right if this firm expects to fully realise the promise they're making for £1billion profit one day. 10p by the end of Summer?

The whole market is down today. We'll have some sort of bounce back tomorrow. Barclays are a bunch of shysters. Been shorting it themselves then put out a negative note. They've been in trouble with the FCA so many times and I can see them getting another knuckle wrap over this. They'll be panic buying soon enough to close their CFD short when Moulding and Allen finally decide to fight back with an interim trading update - nothing stopping them for doing so any time. Analysts are making things up now, comparing THG to Boo Hoo. BH have had a host of problems from bad press over poor working conditions to a returns policy that their customers have been having a laugh with. Higher quality market and much more efficient systems at THG. FT might laugh at the product diversification across THG but customers are buying and the company is growing. Meanwhile Allen just sunk the best part of £1million into shares on the open market. It won't be for no reason.
I agree with many posters here. As soon as Moulding makes the necessary changes for governance all options are on. I think he will.

Great RNS. Quite an underwhelming response so far. The CEO will be doing the rounds today so it should pick up later.

Is good news for retail anyway.

Looks like there will be more resignations. Another junior minister, Morrison just gone to add to Sunak and Javid tonight. Morrison says more will go tomorrow. It will put pressure on the markets alongside the BoE gloomy forecast. I am very much hoping the pressure is on for Moulding to make a decision to go private or to advise on progress and/or strategic plans rather than to do nothing. An RNS would hold us up or give is some forward traction depending on what the plan is. Why bother going through the whole takeover process for no reason? It has done us no good. Be nice if there was method in the madness.

Beza, no mention of a dividend. They have announced they will be buying back shares. Should be helpful.

Well done guys and gals. Looks like an AIHL buy is coming soon.

Permits due to land next week for Tunisia according to the RNS this week. That will sort out the sp. Good time to buy. Thinking of taking a hit on something else and putting the money here.

Good presentation. £4.6 million cash in the bank. They said they won't need a fundraise. 10,000 capacity per month for episwitch test for ICU cancer treatment. That's the main focus of the sales and marketing drive now. Suitable for 15 different types of cancer and they are extending it for new types including bladder cancer and pancreatic cancer. The master services agreement is with big pharma. When the first orders are agreed they will RNS who it is, subject to an NDA atm. Another 5 contracts with another 5 pharma in discussion now.
Pricing structure is variable in line with the cvc code- $1,500_3,000.00 each test. Gets more expensive as demand grows in the US system according to John Burrows, the CEO.
Another 4 big biopharma conferences to go to this year. They are presenting with big pharma at the next ASCO in Paris.
The product should fly. 15% of cancer patients already choose ICU over chemo. Less invasive. But it doesn't work for everyone. Current tests take weeks to process. The EpiSwitch gives an immediate result saving valuable weeks in decision support. They will become the go to test and grow demand for ICU at the same time. I have tweeted one of their slides. But I would recommend you have a listen.
The sp has taken a hit because Armistice Capital have taken warrants and sold their shares. They didn't tell OBD. Shame because they could have organised a swap with Vulpes by the sound of it.
Anyway, new buyers are in at bargain prices.
GLA.

Hmm. Don't agree with you about the tax from the city being a reason for the FCA not to do their job. You'd get much better levels of investment and less traumatic losses for ordinary investors, more people making it work for them if it were more transparent. Govt just dumped a bill that the FCA had lobbied for before the last Queen's speech. Vested interests looking after their own.

I agree. But still, the takeover forced disclosure of loads of undeclared shorts from the whales. Same banks charged with overseeing the separation. Blatant. So would be an easy win for the FCA. It's PIs who lose. People can go on about 'anxious investors ' as much as they like but it's just exploitative. People are playing with their pensions or young people trying to get a house deposit together and we are actually seeing a trend for years of declining investment. Investment is a key driver for the economy.
Anyway, in trying to make sense of it I am betting Allen waited to buy low because he knew that would happen after the bids were rejected and now it's getting closer to news, he's jumped in. If he just wanted to signal confidence without necessarily being confident, there's no way he would have bought a million. Think my £20k is safe and will get a decent return. Anyway, GLA.

So if there was news tomorrow he'd have done nothing wrong. Wouldn't bank on it the way the banks are obviously still shorting. They will probably know too. I have stopped being surprised at the possibility of rule breaking in the city. Since I've been investing I read the FT every day. It's like one long series of scandals. Sadly. They are mostly toying with us. Banks sell so PIs sell. Could be bad news could be good news as far as the shorting is concerned. If it's good news- all the shorting whales are also buying long- they're accumulating much larger positions at lower cost and will close their shorts in good time. Those involved in shorting this are also brokering the deal so they will also know. Best indication that it's good news is Allen's buy. Notice he took his time about it. He's not putting in a million for no reason.
But I do wish the FCA would do their job. Would be g8 if they followed the rules. Less stress for us and you would get more investors. The city are short termist and greedy. Hey ho.

The information on the planned separation is clearly in the public domain. Of course he will have been briefed whether it's happening or not. If it is happening, albeit in a revised context the deadline is August 10th according to the RNS. So he's just inside the rules on that if there were a challenge. But I doubt there would be since there was an RNS on 10th May 2021.

Think it's a little bit naive to imagine the Chairman doesn't know what's happening Pokerchips. He will know all about it I think.

Thx SP. V helpful.

Are results due mid July too?

OK. Thx

Does anyone have a link to the proposal for separation? Checked all the RNS' and I can't see anything. Guessing it came up at an investors presentation? If so it would be helpful if someone could highlight the key points from your notes. Sorry to ask. Only bought THG a couple of months ago. Thx.

Ridiculous drop over £4 million debt. Plenty of buys now! In 2 hours time they will be telling us more about who the big pharma is (I hope otherwise it will be leaked soon enough) and telling us about the pricing structure and the other 'multiple agreements ' with another 5 pharma. No time to sell. Time to buy.